Keywords: Contrast Agents, Whole Body, Blood pooling, perfusion
Motivation: Develop a blood pool MRA contrast agent that provides exceptional vascular images.
Goal(s): Demonstrate that a lipid nanoparticle containing gadolinium (HMRI-101) prolongs useful image acquisition times with 1.5 or 3T MRIs.
Approach: Comparing varying doses of HMRI-101 with small molecule gadolinium-based contrast agents (GBCAs) in rat, pig and primate MRA models.
Results: HMRI-101 provided whole body high resolution MRA images up to 60 minutes at standard field strength and was excreted via the liver, bile, feces. By comparison, other GBCAs provided images up to 10 minutes and were excreted via the kidney.
Impact: A blood pool lipid-based GBCA allows superior vascular images at 1.5 or 3T. Lower doses of gadolinium and route of excretion are of potential safety benefit, and longer imaging times provide greater flexibility and expanded radiological applications.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords